Design Therapeutics (DSGN) Other Non-Current Assets (2022 - 2025)
Design Therapeutics (DSGN) reported Other Non-Current Assets of $427000.0 for Q1 2025, little changed on a YoY basis from $427000.0 in Q1 2024, and little changed sequentially from $427000.0 in Q4 2024.
Design Therapeutics (DSGN) Other Non-Current Assets (2022 - 2025) Analysis & Trends
Design Therapeutics (DSGN) has 4 years of Other Non-Current Assets data on file, last reported at $427000.0 in Q1 2025.
- For the quarter ending Q1 2025, Other Non-Current Assets changed 0.0% year-over-year to $427000.0; the trailing twelve-month figure through Mar 2025 stood at $427000.0 (changed 0.0% YoY), and the FY2024 full-year result was $427000.0, down 0.7% from the prior year.
- Other Non-Current Assets held at $427000.0 in Q1 2025, from $427000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $474000.0 in Q2 2022 to a low of $427000.0 in Q1 2024.
- A 4-year average of $441583.3 and a median of $433500.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets fell 6.33% in 2023 and changed 0.0% in 2025, its largest moves.
- Tracing DSGN's Other Non-Current Assets over 4 years: stood at $459000.0 in 2022, then fell by 6.32% to $430000.0 in 2023, then decreased by 0.7% to $427000.0 in 2024, then changed by 0.0% to $427000.0 in 2025.
- Business Quant data shows DSGN's Other Non-Current Assets at $427000.0 in Q1 2025, $427000.0 in Q4 2024, and $427000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | Design Therapeutics | 714.48 Mn | 491.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 427,000.00 |
| Dec 31, 2023 | 430,000.00 |
| Sep 30, 2023 | 437,000.00 |
| Jun 30, 2023 | 444,000.00 |
| Mar 31, 2023 | 452,000.00 |
| Dec 31, 2022 | 459,000.00 |
| Sep 30, 2022 | 466,000.00 |
| Jun 30, 2022 | 474,000.00 |